Anti Cancer Medicine
Bevacizumab Injection 400mg/16mL Manufacturer in India
Price on Request
Bevacizumab Injection 400mg/16mL Manufacturer in India | Global Supply for Oncology Medicine
Product Highlights
Medicine: Bevacizumab Injection
Strength: 400mg/16mL
Medicine Category: Targeted Biological Therapy
Administration: Intravenous Infusion
Availability: Hospital & Institutional Supply Only
Why Hospitals Choose Bevacizumab
Bevacizumab is widely incorporated into modern oncology treatment strategies because it targets the blood vessels that support tumour growth rather than directly attacking cancer cells. It is frequently combined with chemotherapy or other approved treatment regimens according to the patient's diagnosis and clinical condition.
Cancer Conditions Where It May Be Used
Depending on approved clinical guidelines, Bevacizumab may be selected for treating:
✔ Advanced colorectal cancer
✔ Non-small cell lung cancer
✔ Ovarian cancer
✔ Cervical cancer
✔ Kidney cancer
✔ Brain tumours (glioblastoma)
✔ Liver cancer in approved combination therapy
Dosing Principles
There is no universal dose for Bevacizumab.
The treatment schedule is individualized according to:
Patient body weight
Type of cancer
Combination treatment plan
Clinical response
Overall health condition
Infusions are generally repeated every 2–3 weeks, depending on the oncology protocol.
If Treatment Is Delayed
Because the medicine is administered in hospitals, patients should contact their oncology department if an appointment cannot be attended.
A replacement infusion should only be scheduled by the treating medical team.
Patients should never attempt to change the treatment schedule independently.
In Case of Excess Administration
Administration is supervised by trained healthcare professionals, making overdose uncommon.
If a larger quantity than intended is administered, patients may require observation for complications such as elevated blood pressure, bleeding events, or excessive treatment-related toxicity. Management depends on clinical findings and supportive care.
Storage & Handling
Store according to the manufacturer's recommendations.
Keep the vial protected from freezing and excessive heat.
Inspect the solution before administration.
Use only by trained hospital personnel.
Who can purchase Bevacizumab Injection?
Licensed hospitals, oncology centres, government institutions, and pharmaceutical distributors.
Can Bevacizumab be combined with chemotherapy?
Yes. It is commonly used alongside other anticancer medicines according to approved treatment protocols.
Is one vial equal to one patient treatment?
No. The required quantity depends on the patient's body weight and prescribed treatment regimen.
Does Bevacizumab require cold-chain handling?
Storage and transport should always follow the manufacturer's approved recommendations.
Can international buyers request bulk quotations?
Yes. Commercial export quotations are available for qualified pharmaceutical importers and institutional buyers.
Bevacizumab Injection Manufacturer India
Targeted Cancer Injection Supplier
Buy bevacizumab 400 mg 16 ml.
Generic Oncology Biologic Exporter
VEGF Monoclonal Antibody Supplier
Bevacizumab Hospital Procurement
Cancer Biologic Distributor
Oncology Injection Wholesaler
Bevacizumab Bulk Export
Pharmaceutical Manufacturer, India
Oncology Tender Supplier
Biologic Injection Export Company
Hospital Cancer Medicine Supplier
Anti-VEGF Injection Exporter
International Oncology Medicine Supplier
📞 Contact Ernest Oncology – Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.]
Product Highlights
Medicine: Bevacizumab Injection
Strength: 400mg/16mL
Medicine Category: Targeted Biological Therapy
Administration: Intravenous Infusion
Availability: Hospital & Institutional Supply Only
Why Hospitals Choose Bevacizumab
Bevacizumab is widely incorporated into modern oncology treatment strategies because it targets the blood vessels that support tumour growth rather than directly attacking cancer cells. It is frequently combined with chemotherapy or other approved treatment regimens according to the patient's diagnosis and clinical condition.
Cancer Conditions Where It May Be Used
Depending on approved clinical guidelines, Bevacizumab may be selected for treating:
✔ Advanced colorectal cancer
✔ Non-small cell lung cancer
✔ Ovarian cancer
✔ Cervical cancer
✔ Kidney cancer
✔ Brain tumours (glioblastoma)
✔ Liver cancer in approved combination therapy
Dosing Principles
There is no universal dose for Bevacizumab.
The treatment schedule is individualized according to:
Patient body weight
Type of cancer
Combination treatment plan
Clinical response
Overall health condition
Infusions are generally repeated every 2–3 weeks, depending on the oncology protocol.
If Treatment Is Delayed
Because the medicine is administered in hospitals, patients should contact their oncology department if an appointment cannot be attended.
A replacement infusion should only be scheduled by the treating medical team.
Patients should never attempt to change the treatment schedule independently.
In Case of Excess Administration
Administration is supervised by trained healthcare professionals, making overdose uncommon.
If a larger quantity than intended is administered, patients may require observation for complications such as elevated blood pressure, bleeding events, or excessive treatment-related toxicity. Management depends on clinical findings and supportive care.
Storage & Handling
Store according to the manufacturer's recommendations.
Keep the vial protected from freezing and excessive heat.
Inspect the solution before administration.
Use only by trained hospital personnel.
Who can purchase Bevacizumab Injection?
Licensed hospitals, oncology centres, government institutions, and pharmaceutical distributors.
Can Bevacizumab be combined with chemotherapy?
Yes. It is commonly used alongside other anticancer medicines according to approved treatment protocols.
Is one vial equal to one patient treatment?
No. The required quantity depends on the patient's body weight and prescribed treatment regimen.
Does Bevacizumab require cold-chain handling?
Storage and transport should always follow the manufacturer's approved recommendations.
Can international buyers request bulk quotations?
Yes. Commercial export quotations are available for qualified pharmaceutical importers and institutional buyers.
Bevacizumab Injection Manufacturer India
Targeted Cancer Injection Supplier
Buy bevacizumab 400 mg 16 ml.
Generic Oncology Biologic Exporter
VEGF Monoclonal Antibody Supplier
Bevacizumab Hospital Procurement
Cancer Biologic Distributor
Oncology Injection Wholesaler
Bevacizumab Bulk Export
Pharmaceutical Manufacturer, India
Oncology Tender Supplier
Biologic Injection Export Company
Hospital Cancer Medicine Supplier
Anti-VEGF Injection Exporter
International Oncology Medicine Supplier
📞 Contact Ernest Oncology – Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.]
Enquire About This Product
